Patient characteristics
| Characteristic . | n = 1386 n (%) . |
|---|---|
| Transplant type | |
| Liver | 452 (33) |
| Kidney | 441 (32) |
| Heart | 309 (22) |
| Lung | 110 (8) |
| Intestinal and/or multivisceral | 20 (1) |
| Pancreas | 3 (0.2) |
| Multiple∗ | 51 (4) |
| Sex | |
| Male | 803 (58) |
| Female | 583 (42) |
| Race | |
| White | 620 (45) |
| Black | 242 (17) |
| Asian | 6 (77) |
| Other/unknown | 447 (32) |
| Age at organ transplant, y | |
| Average age (range) | 40 years (21 days to 80 years) |
| <10 | 257 (19) |
| 10-18 | 131 (9) |
| 18-60 | 609 (44) |
| ≥60 | 389 (28) |
| EBV serostatus | |
| High risk (D+/R−) | 229 (17) |
| Intermediate risk (D+/R+, D−/R+) | 1074 (77) |
| Low risk (D−/R−) | 42 (3) |
| Unknown | 41 (3) |
| Peak plasma EBV viral load (IU/mL) | |
| Detectable but not quantifiable | 280 (20) |
| <1000 | 801 (58) |
| 1000-4000 | 139 (10) |
| >4000 | 127 (9) |
| Unknown† | 39 (3) |
| Characteristic . | n = 1386 n (%) . |
|---|---|
| Transplant type | |
| Liver | 452 (33) |
| Kidney | 441 (32) |
| Heart | 309 (22) |
| Lung | 110 (8) |
| Intestinal and/or multivisceral | 20 (1) |
| Pancreas | 3 (0.2) |
| Multiple∗ | 51 (4) |
| Sex | |
| Male | 803 (58) |
| Female | 583 (42) |
| Race | |
| White | 620 (45) |
| Black | 242 (17) |
| Asian | 6 (77) |
| Other/unknown | 447 (32) |
| Age at organ transplant, y | |
| Average age (range) | 40 years (21 days to 80 years) |
| <10 | 257 (19) |
| 10-18 | 131 (9) |
| 18-60 | 609 (44) |
| ≥60 | 389 (28) |
| EBV serostatus | |
| High risk (D+/R−) | 229 (17) |
| Intermediate risk (D+/R+, D−/R+) | 1074 (77) |
| Low risk (D−/R−) | 42 (3) |
| Unknown | 41 (3) |
| Peak plasma EBV viral load (IU/mL) | |
| Detectable but not quantifiable | 280 (20) |
| <1000 | 801 (58) |
| 1000-4000 | 139 (10) |
| >4000 | 127 (9) |
| Unknown† | 39 (3) |
Multiple transplant group includes both sequential and simultaneous organ transplants in the following combinations: liver/lung, kidney/pancreas, kidney/liver, heart/liver, and heart/kidney.
Patients who had EBV DNAemia detected in whole blood (copies per milliliter) but who did not have a plasma assay to confirm EBV viral load in international units per milliliter.